Blepharochalasis left lower eyelid
ICD-10 H02.35 is a billable code used to indicate a diagnosis of blepharochalasis left lower eyelid.
Blepharochalasis of the left lower eyelid is characterized by the recurrent swelling and subsequent relaxation of the eyelid skin, leading to excess skin and a drooping appearance. This condition primarily affects the lower eyelid, resulting from repeated episodes of edema and inflammation, which can be associated with allergic reactions, systemic diseases, or idiopathic causes. The anatomy involved includes the eyelid structure, which consists of skin, muscle (orbicularis oculi), and connective tissue, as well as the underlying lacrimal system that may be affected by the condition. Disease progression can lead to cosmetic concerns and potential functional impairment, such as obstructed vision due to eyelid droop. Diagnostic considerations include a thorough patient history, physical examination, and possibly imaging studies to rule out underlying causes. The condition is often diagnosed clinically, and treatment options may include surgical intervention for severe cases or conservative management for mild presentations.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
H02.35 specifically covers blepharochalasis of the left lower eyelid, which may be associated with recurrent eyelid swelling and excess skin. It does not cover other eyelid conditions such as ptosis or dermatochalasis unless specified.
H02.35 should be used when the condition specifically affects the left lower eyelid and is characterized by the features of blepharochalasis. It is important to differentiate it from other eyelid disorders based on clinical findings.
Documentation should include a detailed history of the patient's symptoms, clinical examination findings, and any relevant imaging studies. Notes should clearly indicate the diagnosis of blepharochalasis and the impact on the patient's function or quality of life.
